Qnovia, Inc. Announces Former Director of FDA’s Center for Tobacco Products, Mitch Zeller, as Policy and Regulatory Strategy Advisor

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today Mitch Zeller has joined the company as an advisor to focus on policy and regulatory strategy. Qnovia’s lead asset, QN-01, is an application to FDA’s Center for Drug Evaluation and Research (CDER), with the potential to be … [Read more…]

Scorpion Therapeutics and Pierre Fabre Announce Collaboration and License Agreement to Co-Develop and Commercialize STX-721 and STX-241 for Patients with EGFR Mutant Non-Small Cell Lung Cancer

— Scorpion receives $65 million from an upfront payment and the achievement of near-term milestones and is eligible to receive up to $553 million in potential milestones, plus royalties on net product sales — — Scorpion will retain rights to STX-721 and STX-241 in the United States, Canada and Japan; Pierre Fabre granted rights in … [Read more…]

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 26, 2023

WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the first quarter 2023 before the market opens on Wednesday, April 26, 2023, and will hold a conference call on the same day at 8:30 a.m. EST. During the call, the company … [Read more…]

Boundless Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in oncogene amplified cancers, today announced that its Chief Business Officer, Neil Abdollahian, will present at the 22nd Annual Needham Healthcare Conference which will take place virtually. Presentation details are as follows: Date: Tuesday, April 18, 2023 Time: … [Read more…]

HealthPlan Data Solutions launches new self-service Spotlight Platform to bring unparalleled insight into pharmacy claims data

– HDS launches new SaaS-based pharmacy claims data platform, Spotlight – Website refresh displays new, comprehensive suite of product offerings – Spotlight provides healthcare payers the opportunity to access actionable insights and drive greater visibility into their pharmacy benefit spend COLUMBUS, Ohio–(BUSINESS WIRE)–HealthPlan Data Solutions, Inc. (HDS) today announced the launch of their first self-service … [Read more…]

DentalMonitoring Announces Braces Monitoring Innovations

AUSTIN, Texas–(BUSINESS WIRE)–DentalMonitoring continues to set the standard in AI-powered orthodontic solutions, with two innovative features that allow doctors to better visualize progress and obstacles throughout treatment. An update to the platform including the new patient timeline and progress bar is now available in the dashboard for doctors worldwide. With the new patient timeline and … [Read more…]

Shionogi Receives U.S. FDA Fast Track Designation for Ensitrelvir Fumaric Acid, an Investigational Oral Antiviral for COVID-19

OSAKA, Japan–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for their investigational COVID-19 oral antiviral ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter “ensitrelvir”). FDA Fast Track designation is … [Read more…]

Silence Therapeutics Announces Publication in Blood Demonstrating Role for Iron Regulation in Polycythemia Vera

– Study provides therapeutic rationale for SLN124, Silence’s clinical candidate for polycythemia vera and other hematological disorders LONDON–(BUSINESS WIRE)–$SLN #SenseofSilence–Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precision engineered medicines, today announced publication of human genomic and in vivo … [Read more…]

Bicara Therapeutics to Present Preclinical Data from Clinical-Stage Bifunctional Antibody Program, BCA101, at AACR Annual Meeting 2023

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bicara Therapeutics, a clinical-stage biotechnology company developing dual-action biologics to elicit a potent and durable immune response, today announced that it will present preclinical data supporting the ongoing clinical development of the lead investigational candidate BCA101, a bifunctional antibody designed to sequester the immunosuppressive TGF-β in the tumor microenvironment (TME) of EGFR+ tumors, … [Read more…]

Dilon Technologies Selects AcuityMD Platform to Accelerate its Preventative Breast Cancer Surgery Devices to More Oncologists

AcuityMD enables Dilon to quickly identify the right doctors and medical facilities in urgent need of its life-saving medical technology BOSTON–(BUSINESS WIRE)–AcuityMD, providers of a novel commercial platform for medical technology (MedTech) companies, has signed a multi-year contract with Dilon Technologies, a global leader in devices for breast cancer treatment and diagnosis. Dilon is using … [Read more…]